At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 98 enrolled
Drug / intervention
A-101 Solution 40 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Solution in Subjects With Common Warts.
In Brief
A Phase 2 clinical trial evaluating A-101 Solution 40, A-101 Solution 45, and 1 other intervention for Common Warts. Completed, enrolled 98 participants across 1 site.
Detailed Summary
This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Warts
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
First PostedFeb 2016
Primary CompletionSep 2016
TodayJul 2026
First PostedFeb 1, 2016
Enrollment StartDec 21, 2015
Primary CompletionSep 16, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.4 years ago
Interventions
A-101 Solution 40drug
A-101 Solution 45drug
Vehicle Solutiondrug